Skip to main content
. 2013 May 22;8:565–572. doi: 10.2147/CIA.S44926

Table 1.

Clinical characteristics, cognitive and functional outcomes in GMU patients (n = 228) at baseline

Total (n = 228) Hyperactive (n = 117) Hypoactive (n = 42) Mixed (n = 69)
Demographics
Age (mean ± SD) 84.2 (7.4) 83.6 (7.5) 84.9 (7.8) 84.7 (6.9)
Gender (male %) 43.4 42.7 47.6 42.0
Race (Chinese %) 88.2 93.2 80.9 84.1
Comorbidities
Charlson Comorbidity Index score35 2.3 (1.6) 1.9 (1.3)+ 2.9 (2.20) 2.5 (1.6)*
Severity of Illness Index score36 2.0 (0.3) 2.1 (0.2) 2.0 (0.3) 2.0 (0.4)
Days of delirium 6.7 (4.6) 5.8 (3.1) 7.3 (6.0) 7.9 (5.6)*,#
Length of stay 15.1 (9.3) 13.9 (7.1) 15.0 (10.4) 16.6 (11.4)
Precipitating causes of delirium
Number of precipitating causes, n (%)
 Single precipitating cause 67 (29.4%) 34 (29.1%) 9 (21.4%) 24 (34.8%)
 Two precipitating causes 72 (31.6%) 38 (32.5%) 13 (31.0%) 21 (30.4%)
 More than two precipitating causes 89 (39.0%) 45 (38.5%) 20 (47.6%) 24 (34.8%)
Type of precipitating cause, n (%)
 Sepsis 155 (68.0%) 75 (64.1%) 29 (69.0%) 51 (73.9%)
 Other medical cause 48 (21.1%) 28 (23.9%) 8 (19.0%) 12 (17.4%)
 Postoperative 7 (3.1%) 4 (3.4%) 1 (2.4%) 2 (2.9%)
 Other surgical cause 18 (7.9%) 10 (8.5%) 4 (9.5%) 4 (5.8%)
Cognitive status
Prior dementia diagnosis (%) 46.1 44.4 45.2 49.3
Newly diagnosed dementia during admission (%) 30.3 33.3 33.3 23.1
Prior behavioral issues before admission (%) 25.1 27.4 9.8 30.4*
Initial CMMSE37 (/28) 5.8 (5.5) 6.9 (5.9)+ 4.3 (5.3) 4.9 (4.4)*
Last CMMSE (/28) 9.2 (6.6) 10.5 (6.4) 7.8 (7.2)++ 7.9 (6.0)*
Change in CMMSE (/28) 3.4 (5.5) 3.6 (5.2) 3.5 (6.6) 3.0 (5.3)
Initial CAM33 5.1 (2.0) 5.2 (2.5) 5.3 (1.2) 5.0 (1.2)
Last CAM 2.2 (1.2) 1.9 (0.9) 2.3 (1.3) 2.5 (1.4)
Change in CAM −2.9 (2.3) −3.2 (2.7) −3.0 (1.4) −2.4 (1.8)
Initial DRS severity34 (/39) 22.5 (5.8) 21.6 (6.3) 23.1 (5.6) 23.6 (4.7)
Last DRS severity (/39) 14.6 (6.1) 13.5 (95.5) 16.0 (7.0) 15.4 (6.3)*
Change in DRS severity (/39) −6.2 (6.3) −6.4 (5.8) −5.3 (6.2) −6.2 (7.1)
Initial DRS total (/46) 26.2 (6.1) 25.3 (6.5) 26.9 (5.7) 27.3 (5.4)
Last DRS total (/46) 16.3 (6.7) 15.2 (5.9) 17.8 (7.7) 17.2 (7.2)
Change in DRS total (/46) −11.6 (6.1) −11.7 (5.9) −10.9 (5.7) −11.8 (6.9)
Initial DRS subitem sleep–wake disturbance (/3) 1.9 (0.8) 1.8 (0.8) 1.9 (0.9) 1.9 (0.6)
Last DRS subitem sleep–wake disturbance (/3) 0.7 (0.8) 0.7 (0.8) 0.6 (0.7) 0.6 (0.9)
Change in DRS subitem sleep–wake disturbance (/3) −1.2 (1.1)** −1.1 (1.1)** −1.3 (0.9)** −1.4 (1.3)**
Functional scores
MBI38 admission (/100) 29.1 (24.1) 36.8 (25.9) 16.9 (18.7) 23.4 (19.2)*
MBI discharge (/100) 47.4 (26.1) 56.4 (22.5) 30.9 (26.3) 42.3 (25.7)*
Improvement in MBI scores 18.4 (18.1)** 19.6 (18.6)** 14.0 (2.5)** 19.0 (18.4)**
Pharmacological agent use
Chemical restraints (%) 39.5 47.9 9.5 43.5*
Total antipsychotic use (CPZ equivalent) 0.9 (1.6) 1.2 (1.6) 0 (0) 1.0 (1.7)
Benzodiazepine usage (%) 24.6 26.5 9.5 30.4

Notes:

*

ANOVA P < 0.05 across delirium subtypes;

**

paired sample t-test P < 0.05 for GMU cohort and specific delirium subtypes;

+

post hoc results (with Bonferroni correction) between hyperactive delirium and hypoactive delirium (P < 0.05);

++

post hoc results (with Bonferroni correction) between hypoactive delirium and mixed delirium (P < 0.05);

#

post hoc results (with Bonferroni correction) between hyperactive delirium and mixed delirium (P < 0.05).

Abbreviations: ANOVA, analysis of variance; CAM, Confusion Assessment Method; CMMSE, Chinese Mini−Mental State Examination; CPZ, chlorpromazine; DRS, Delirium Rating Scale; GMU, Geriatric Monitoring Unit; MBI, modified Barthel Index; SD, standard deviation.